FDA NDC Directory · JSON-LD · Markdown

POTELIGEO

NDC 42747-761 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namemogamulizumab-kpkc
Labeler / ManufacturerKyowa Kirin, Inc.
Marketing categoryBiologic License Application · App BLA761051
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsMOGAMULIZUMAB (4 mg/mL)
Marketing started20180808
Package count1

External sources

Source: openFDA. Public-domain (CC0).